Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
Abstract: The objective of this study was to determine if a single loading dose (LD), 3× the label dose of firocoxib oral paste, followed by nine maintenance doses at the current label dose achieves and maintains near steady state concentrations. Six healthy, adult mares were administered 0.3mg/kg of firocoxib on Day 0, and 0.1 mg/kg 24 h later on Day 1, and at 24 h intervals from Day 2 to Day 9, for a total of 10 doses. Blood samples were collected throughout the study. The mean firocoxib maximum plasma concentration and standard deviation was 199±97 ng/mL, 175±44 ng/mL and 183±50 ng/mL after the LD, and first and last maintenance doses, respectively. The minimum mean concentration (C(min)) increased from 100±23 ng/mL after the LD to 132±38 ng/mL at Day 7. Then, the C(min) remained constant until Day 9. The average concentration at steady state (C(avg)) was 150±45 ng/mL, which compares well to the C(avg) (130±36 ng/mL) reported after multiple daily doses at 0.1 mg/kg. The administration of the single LD allowed achievement of the average steady state drug concentrations faster than a multi-dose regimen without a loading dose. After the LD, firocoxib at 0.1 mg/kg every 24 h was able to maintain a relatively constant average drug concentration which should produce less variability in onset of action and efficacy.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Publication Date: 2013-09-04 PubMed ID: 24076125DOI: 10.1016/j.tvjl.2013.07.035Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research studied the impact of a single large dosage (loading dose) followed by smaller and regular maintenance doses of firocoxib on horses. The key finding is that this approach maintained near steady levels of the drug in the horse’s bloodstream, achieving steady state quicker and with less variability than a regimen without a loading dose.
Objective and Methodology
- This research investigated the use of a loading dose (LD) and multiple regular doses of firocoxib, a type of anti-inflammatory drug, in horses. The goal was to see whether these administration strategies would achieve and maintain steady levels of the drug in the animals’ plasma.
- Six healthy, adult mares were given a single loading dose of firocoxib at three times the standard dose. This was followed by nine maintenance doses administered at the label dose over subsequent days.
- Blood samples were taken at regular intervals over the course of the study to monitor the levels of firocoxib in the horses’ plasma.
Study Findings
- The analysis of the plasma samples suggested that the use of a loading dose followed by regular maintenance doses effectively established and maintained near steady concentrations of firocoxib.
- The peak plasma concentration levels (the highest level of the drug in the blood after administration) were consistent across the loading dose and the first and last maintenance doses.
- Moreover, the minimum mean concentration levels (the lowest level of the drug in the blood before the next dose) increased after the loading dose and then remained stable up until day 9.
- The average concentration at steady state (the average level of the drug in the blood over time) was found to be comparable to levels reported in previous studies that used multiple daily doses without a loading dose.
Conclusion
- The study concluded that administering a single loading dose of firocoxib, followed by regular maintenance doses, allowed for quicker attainment of average steady-state drug concentrations than a regimen without a loading dose. This method also resulted in less variability in terms of the onset of action and efficacy.
- This approach to drug administration may prove beneficial in optimizing the pharmacological effects of firocoxib in horses, potentially leading to more efficient and effective treatment plans.
Cite This Article
APA
Cox S, Villarino N, Sommardahl C, Kvaternick V, Zarabadipour C, Siger L, Yarbrough J, Amicucci A, Reed K, Breeding D, Doherty T.
(2013).
Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
Vet J, 198(2), 382-385.
https://doi.org/10.1016/j.tvjl.2013.07.035 Publication
Researcher Affiliations
- University of Tennessee, Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, 2407 River Drive, Knoxville, TN 37996, USA. Electronic address: scox6@utk.edu.
MeSH Terms
- 4-Butyrolactone / analogs & derivatives
- 4-Butyrolactone / blood
- 4-Butyrolactone / pharmacokinetics
- Administration, Oral
- Animals
- Anti-Inflammatory Agents, Non-Steroidal / blood
- Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
- Area Under Curve
- Chromatography, High Pressure Liquid / veterinary
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Half-Life
- Horses / metabolism
- Sulfones / blood
- Sulfones / pharmacokinetics
- Time Factors
Citations
This article has been cited 7 times.- Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses.. Animals (Basel) 2023 May 10;13(10).
- Fadel C, Giorgi M. Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses.. Vet Anim Sci 2023 Mar;19:100286.
- Jacobs CC, Schnabel LV, McIlwraith CW, Blikslager AT. Non-steroidal anti-inflammatory drugs in equine orthopaedics.. Equine Vet J 2022 Jan 25;54(4):636-48.
- Ziegler AL, Blikslager AT. Sparing the gut: COX-2 inhibitors herald a new era for treatment of horses with surgical colic.. Equine Vet Educ 2020 Nov;32(11):611-616.
- Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis.. Vet Med (Auckl) 2014;5:159-168.
- Ziegler AL, Freeman CK, Fogle CA, Burke MJ, Davis JL, Cook VL, Southwood LL, Blikslager AT. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.. Equine Vet J 2019 May;51(3):329-335.
- Whitfield-Cargile CM, Chamoun-Emanuelli AM, Cohen ND, Richardson LM, Ajami NJ, Dockery HJ. Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses.. PLoS One 2018;13(8):e0202527.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists